Regentis Biomaterials RGNT Balance Sheet (2024-2026)

NYSE RGNT
$1.85 +0.00 (+0.00%)
As of: Sep 30, 2026 · 3:36 PM EDT
Reported Financials

Regentis Biomaterials Quarterly Balance Sheet

Periods 3 quarters
Latest Jun 2026

Regentis Biomaterials reported total assets of $9.35M and total liabilities of $1.67M for the quarter ended Jun 2026. This balance sheet covers 3 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2024 Dec2025 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 0.23M7.38M8.95M
Cash & Current Investments 0.23M7.38M8.95M
Prepaid Assets 0.18M0.24M0.33M
Current Assets 7.62M9.29M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net) 0.03M
Non-Current Assets 0.06M
Assets 0.48M7.62M9.35M
Liabilities
Current Liabilities
Accounts Payables 0.25M0.27M0.20M
Notes Payables 0.57M1.20M
Payables 0.82M1.46M0.20M
Accumulated Expenses 1.13M1.39M1.00M
Other Accumulated Expenses 1.20M0.50M
Short term Debt 4.37M
Total Current Liabilities 6.49M2.87M1.65M
Non-Current Liabilities
Preferred Stock Liabilities 35.10M
Operating Leases 0.02M
Other Non-Current Liabilities 0.16M
Total Non-Current Liabilities 41.43M
Total Liabilities 41.59M2.87M1.67M
Shareholder's Equity
Total Debt 4.95M1.20M
Common Equity -41.10M4.74M7.68M
Liabilities and Shareholders Equity 0.48M7.62M9.35M
Retained Earnings -42.15M-55.79M-58.39M

Regentis Biomaterials Balance Sheet API

Pull Regentis Biomaterials's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RGNT&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY